Risk factor
Low price volatility
Profitability factor
Undervalued vs peers
About
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, trading at neutral le
Target Price
The average target price of 086450.KQ is 23000 and suggests 23% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Buy
Sell